Halaven Caution For Usage

Special precautions for disposal and other handling: Any unused product or waste material should be disposed of in accordance with local requirements.
HALAVEN is a cytotoxic anticancer medicinal product and, as with other toxic compounds, caution should be exercised in handling HALAVEN. The use of gloves, goggles, and protective clothing is recommended. If the solution contacts the skin, the skin should be washed immediately and thoroughly with soap and water. If it contacts mucous membranes, the membranes should be flushed thoroughly with water. HALAVEN should only be prepared and administered by personnel appropriately trained in handling of cytotoxic agents. Pregnant staff should not handle HALAVEN.
Using aseptic technique HALAVEN can be diluted up to 100 ml with sodium chloride 9 mg/ml (0.9%) solution for injection. Following administration, it is recommended that the intravenous line be flushed with sodium chloride 9 mg/ml (0.9%) solution for injection to ensure administration of the complete dose. It must not be mixed with other medicinal products and should not be diluted in glucose 5% infusion solution.
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
HALAVEN solution for injection should not be diluted in glucose 5% infusion solution.